Carefusion Corp (CFN) 59.91 $CFN
Uptrend Call Working As CareFusion Stock Rises 34.9% (CFN)
Comtex SmarTrend(R) - Thu Mar 19, 9:28AM CDT
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 7 months, CareFusion has returned 34.93% as of today's recent price of $59.91.
CFN: 59.91 (-0.06)
Fitch Affirms CareFusion at 'BBB'; Withdraws All Ratings
Business Wire - Wed Mar 18, 4:36PM CDT
Fitch Ratings has affirmed the ratings of CareFusion Corp. (CareFusion) at 'BBB' following its acquisition by Becton Dickinson & Co. (NYSE: BDX). The Positive Rating Watch is removed and a Stable Rating Outlook is assigned.
BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
Becton Dickinson Completes Acquisition Of CareFusion
PR Newswire - Tue Mar 17, 8:00AM CDT
Becton, Dickinson and Company (NYSE: BDX) ("BD"
today announced that it completed its acquisition of CareFusion Corporation ("CareFusion" pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement" .
BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
Jim Cramer: The S&P 500 Isn’t as Passive as You Might Think
at The Street - Tue Mar 17, 5:00AM CDT
It's like a big-league franchise with a fantastic farm team.
VRX: 204.26 (+2.17), BDX: 144.72 (-0.21), ACT: 317.06 (+2.65), MDT: 78.02 (+0.36), NBR: 13.15 (+0.36), SLG: 134.00 (+3.58), SDRL: 9.83 (+0.46), GHC: 1,085.05 (+6.36), DO: 27.68 (+0.68), RCL: 79.98 (unch), RIG: 14.99 (+0.83), CFN: 59.91 (-0.06), JBL: 23.65 (+0.30), HBI: 34.18 (-0.16), DNR: 7.46 (-0.04), HSIC: 143.01 (+2.32), URI: 88.85 (+0.37), MNK: 132.47 (+1.26), ENDP: 92.37 (+0.89), AVP: 7.63 (+0.35), SWKS: 102.05 (+2.48), UHS: 118.76 (+0.03), NFLX: 428.30 (+3.09), HCA: 76.03 (+0.61), BTU: 6.14 (+0.40), LVLT: 55.40 (+0.73), EQIX: 238.95 (+3.05), ESV: 21.05 (+0.25), RDC: 18.62 (-0.30), PETM: 82.98 (+0.03)
Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market
at The Street - Mon Mar 16, 7:15PM CDT
It's creating investment opportunities that just shouldn't exist, Cramer says.
KMI: 42.12 (+0.59), TSLA: 198.08 (+2.43), BIIB: 475.98 (+42.33), MMM: 166.49 (+0.83), ACT: 317.06 (+2.65), SHAK: 46.92 (-0.65), PCYC: 257.85 (-0.21), BMRN: 125.17 (-2.32), NBR: 13.15 (+0.36), SLG: 134.00 (+3.58), RRD: 19.23 (+0.41), CFN: 59.91 (-0.06), TRN: 35.28 (+1.28), CMG: 686.65 (+5.98), HBI: 34.18 (-0.16), DNR: 7.46 (-0.04), PEIX: 10.77 (+0.27), OA: 78.23 (+1.51), HSIC: 143.01 (+2.32), REGN: 488.87 (+2.85), CSCO: 28.44 (+0.18), HRB: 32.90 (+0.61), HYH: 49.26 (+1.03), MU: 28.68 (+0.63), AVP: 7.63 (+0.35), HAR: 136.52 (-0.31), ETN: 68.48 (+0.90), EW: 146.77 (-2.17), DIS: 108.43 (+1.06), AMGN: 170.10 (+0.99), SN: 11.80 (+0.08), BA: 154.50 (+0.39), VOD: 33.96 (+0.81), AA: 12.97 (+0.01), EQIX: 238.95 (+3.05), ISIS: 73.59 (-3.49), ONCE: 69.95 (-4.22), ICPT: 290.98 (+2.47), ULTA: 152.02 (-0.27), VZ: 49.56 (+0.26)
European Regulator Oks Becton, Dickinson-CareFusion Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 12:10PM CDT
Becton, Dickinson and Company (BDX) recently received European Commission's approval for its pending acquisition of CareFusion Corp (CFN).
BDX: 144.72 (-0.21), CAH: 91.25 (+1.33), CFN: 59.91 (-0.06), MMSI: 19.40 (-0.02)
CareFusion (CFN) Crosses Pivot Point Resistance at $60.07
Comtex SmarTrend(R) - Mon Mar 16, 10:48AM CDT
Shares of CareFusion (NYSE:CFN) opened today above their pivot of $59.95 and have already reached the first level of resistance at $60.07. Analysts will be watching for a cross of the next upside pivot targets of $60.16 and $60.37.
CFN: 59.91 (-0.06)
Becton, Dickinson and Company passes European Commission clearance for pending acquisition of CareFusion
M2 - Mon Mar 16, 4:36AM CDT
Medical technology company Becton, Dickinson and Company (NYSE:BDX) reported on Friday the receipt of clearance from the European Commission for the pending acquisition of CareFusion Corporation (NYSE:CFN).
BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P 500, S&P MidCap 400 and S&P SmallCap 600
PR Newswire - Fri Mar 13, 4:50PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
KMI: 42.12 (+0.59), BDX: 144.72 (-0.21), AVP: 7.63 (+0.35), ACT: 317.06 (+2.65), TLMR: 14.77 (-0.05), NBR: 13.15 (+0.36), FCX: 18.41 (+1.15), SLG: 134.00 (+3.58), MHFI: 108.59 (+1.08), BWLD: 187.16 (-1.00), CELG: 128.50 (+3.17), NOV: 49.66 (+1.77), EQIX: 238.95 (+3.05), CFN: 59.91 (-0.06), APA: 59.55 (-0.33), HBI: 34.18 (-0.16), DNR: 7.46 (-0.04), HSIC: 143.01 (+2.32), CELGZ: 3.05 (+0.02)
European Commission Clears BD Acquisition Of CareFusion
PR Newswire - Fri Mar 13, 1:00PM CDT
Becton, Dickinson and Company (NYSE: BDX) ("BD" and CareFusion Corporation (NYSE: CFN) ("CareFusion" announced today that the companies have received clearance from the European Commission under the EU Merger Regulation for the pending acquisition of CareFusion by BD. The proposed acquisition has now received all necessary regulatory approvals.
BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
CareFusion Shares Up 34.3% Since SmarTrend's Buy Recommendation (CFN)
Comtex SmarTrend(R) - Wed Mar 11, 5:05PM CDT
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 7 months, CareFusion has returned 34.30% as of today's recent price of $59.63.
CFN: 59.91 (-0.06)
Healthcare IT Market in India 2015-2019: Healthcare Providers and Institutions Adopting Corporate Culture with Dell, HCL, HP, TCS & Wipro Dominating
M2 - Tue Mar 10, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/693hmv/healthcare_it) has announced the addition of the "Healthcare IT Market in India 2015-2019" report to their offering. The Healthcare IT market in India to grow at a CAGR of 14.02% over the period 2014-2019 This report covers the present scenario and the growth prospects of the Healthcare IT market in India for the period 2015-2019. The Healthcare IT market is categorized into three segments: Hardware, Software, and IT Services. Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is contributing to the growth of healthcare IT. The demand for advanced analytics tools is one of the key trends in the market. These tools are a significant part of healthcare data analytics solutions, which help healthcare professionals or organizations gain insights from medical records of patients collected from various sources. According to the report, healthcare providers and institutions are increasingly adopting corporate culture, which is fueling demand for IT solutions in the Healthcare industry. Profits are evidently becoming a priority for several hospitals based out of urban India. Further, the report states that high costs of IT adoption are a main concern in India. Healthcare costs are expected to increase rapidly. The initial investment required for installing IT systems is high and continues to increase; however, revenue does not increase proportionally. Varied healthcare practices make it difficult for physicians to invest in installing and maintaining IT systems. Key Vendors - Dell - HCL - HP - TCS - Wipro Other Prominent Vendors - 21st Century Informatics - Accenture - Akhil Systems - Blackberry - C Marc - CareFusion - Cerner - CGEY - Cognizant - CSC - Emdeon - FCG - GE Healthcare - Google - IBM - Infosys - Intel - Isoft - Kaiser Permanente - Microsoft - Misys - Napier Healthcare - Perot Systems - Philips - Qualcomm - Religare Technova - Shivam Medisoft - Siemens - Tech Mahindra - United Healthcare Group For more information visit http://www.researchandmarkets.com/research/69...lthcare_it
WIT: 13.77 (+0.28), IBM: 162.88 (+3.07), CFN: 59.91 (-0.06), QCOM: 70.04 (+0.21), PER: 6.84 (+0.25), CERN: 73.73 (-0.09)
Top 100 Foreign Medical Devices/Technology/Supplies Companies Active in India: 2015
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9rw4tk/foreign_medical) has announced the addition of the "Foreign Medical Devices/Technology/Supplies Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. India's free market environment, developed industry, investment in health infrastructure, increased demand for high quality medical devices, and agreements between foreign device manufacturers and Indian manufacturers are some of the main factors that are responsible for the growth of the Indian medical market. In a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. However, there are presently a sizable number of foreign firms actively pursuing their businesses in India in this sector. The international companies in this field are using India as a manufacturing base by either setting up facilities of their own or by acquiring domestic manufacturers. And, FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. These 100 foreign companies are a stepping-stone to enter India and therefore this report would be beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of foreign countries active in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances with Indian companies - India presence of foreign medical devices/technology/supplies companies - R&D activities by foreign medical devices/technology/supplies companies in India Companies Mentioned - Accuray Inc (United States) - Accuray medical equipment (India) Private Limited - Alcon Japan Ltd.(Japan) - Alcon Laboratories (India) Pvt. Ltd. - Alpha Pro Tech Limited (Canada) - Ambu A/S (Denmark) - Ambu India - Amplifon India Pvt. Ltd. - Amplifon SPA (Italy) - Asahi Intecc Co., Ltd. (Japan) - B. Braun Aesculap Japan Co., Ltd.(Japan) - B.Braun Medical India Pvt. Ltd. - B.L.J. Company Limited(Japan) - BD India Pvt. Ltd. - Bard India Healthcare Private Limited - Bausch & Lomb Eyecare (India) Pvt. Ltd. - Becton, Dickinson and Company (United States) - Boston Scientific Corporation (United States) - Boston Scientific India Pvt. Ltd. - C R Bard Inc (United States) - CHC Group India - CHC Healthcare Group (Taiwan) - CareFusion Development Pvt. Ltd. - Carefusion Corporation (United States) - Coloplast (India) Pvt. Ltd. - Coloplast AS (Denmark) - Coltene Holding AG (Switzerland) - Coltene/Whaledent Private Ltd. - Conmed Corporation (United States) For more information visit http://www.researchandmarkets.com/research/9r...gn_medical
BSX: 17.84 (+0.03), CFN: 59.91 (-0.06), APT: 2.25 (-0.01), ARAY: 8.99 (+0.17)
Hottest Fashion Trends In Stocks - Cramer's Mad Money (2/17/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Feb 18, 6:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, February 17. With the ongoing Fashion Week in New York, Cramer decided to look at the hottest trends on Wall Street. The cyber-security stocks are in style...
GD: 135.41 (+0.13), BDX: 144.72 (-0.21), LMT: 203.77 (+1.58), MDT: 78.02 (+0.36), CYBR: 48.69 (-1.72), SKX: 71.41 (-0.55), KORS: 66.13 (-0.69), INTC: 31.31 (+0.57), PANW: 144.08 (-2.11), SLB: 82.37 (+1.36), BSX: 17.84 (+0.03), FOSL: 83.20 (+0.67), RIG: 14.99 (+0.83), CFN: 59.91 (-0.06), TGT: 81.31 (+0.71), COST: 152.59 (+1.28), AAPL: 125.90 (-1.60), CSCO: 28.44 (+0.18), WFM: 53.97 (+0.35), HRS: 72.75 (+0.57), MU: 28.68 (+0.63), CY: 15.70 (+0.28), HD: 117.49 (+2.33), FEYE: 41.69 (-1.33), BRCM: 46.00 (+1.12), VFC: 75.25 (+1.19), EW: 146.77 (-2.17), TRIP: 86.35 (+2.55), COLM: 59.58 (+0.33), SMH: 57.74 (+0.90), WM: 54.55 (-0.18), PCLN: 1,179.17 (+2.85), WWAV: 42.67 (+0.37), BBBY: 74.87 (-0.74), TJX: 69.47 (+1.31), EXPE: 95.91 (+1.23), JWN: 82.32 (+1.12), FTNT: 35.31 (-0.16), BIG: 50.14 (+0.10)
Insider Trading Alert - CFN, VSR And CAVM Traded By Insiders
at The Street - Wed Feb 11, 11:16AM CST
Stocks with insider trader activity include CFN, VSR and CAVM
CAVM: 73.81 (+1.33), CFN: 59.91 (-0.06), VSR: 3.28 (+0.21)
CareFusion Up 34.5% Since SmarTrend Uptrend Call (CFN)
Comtex SmarTrend(R) - Tue Feb 10, 5:04PM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 6 months, CareFusion has returned 34.46% as of today's recent price of $59.70.
CFN: 59.91 (-0.06)
CareFusion to Distribute Breas Medical's Vivo Ventilators in US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 1:28PM CST
CareFusion Corp (CFN) recently announced the signing of an exclusive distribution agreement with Breas Medical for the latter's Vivo line of ventilation equipment.
BDX: 144.72 (-0.21), ABAX: 65.61 (+1.33), CFN: 59.91 (-0.06), VASC: 30.35 (-0.02)
Codonics and CareFusion Expand Partnership
PR Newswire - Tue Feb 10, 7:40AM CST
Codonics (codonics.com), a global leader in medication safety systems and image documentation solutions, and CareFusion (carefusion.com), a leading global medical technology company, are pleased to announce their expanded partnership. Codonics and CareFusion are working together to develop advanced integration between Codonics technology, CareFusion solutions and Pharmacy Information System (PIS), delivering synchronized formulary management to the operating room (OR).
CFN: 59.91 (-0.06)
Apnea Sciences Announces CareFusion Signs Agreement to Distribute ApneaRx(R)
Business Wire - Mon Feb 09, 9:00AM CST
After Kaiser Permanente Hospitals agreed to purchase Apnea Sciences patented treatment for sleep apnea, ApneaRx(R), www.apnearx.com they needed an experienced distributor. Apnea Sciences selected California-based CareFusion www.carefusion.com to manage all phases of distribution.
CFN: 59.91 (-0.06)
Uptrend Call Working As CareFusion Stock Rises 34.9% (CFN)
Comtex SmarTrend(R) - Thu Mar 19, 9:28AM CDT
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 7 months, CareFusion has returned 34.93% as of today's recent price of $59.91.
CFN: 59.91 (-0.06)
Fitch Affirms CareFusion at 'BBB'; Withdraws All Ratings
Business Wire - Wed Mar 18, 4:36PM CDT
Fitch Ratings has affirmed the ratings of CareFusion Corp. (CareFusion) at 'BBB' following its acquisition by Becton Dickinson & Co. (NYSE: BDX). The Positive Rating Watch is removed and a Stable Rating Outlook is assigned.
BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
Becton Dickinson Completes Acquisition Of CareFusion
PR Newswire - Tue Mar 17, 8:00AM CDT
Becton, Dickinson and Company (NYSE: BDX) ("BD"
today announced that it completed its acquisition of CareFusion Corporation ("CareFusion" pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement" . BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
Jim Cramer: The S&P 500 Isn’t as Passive as You Might Think
at The Street - Tue Mar 17, 5:00AM CDT
It's like a big-league franchise with a fantastic farm team.
VRX: 204.26 (+2.17), BDX: 144.72 (-0.21), ACT: 317.06 (+2.65), MDT: 78.02 (+0.36), NBR: 13.15 (+0.36), SLG: 134.00 (+3.58), SDRL: 9.83 (+0.46), GHC: 1,085.05 (+6.36), DO: 27.68 (+0.68), RCL: 79.98 (unch), RIG: 14.99 (+0.83), CFN: 59.91 (-0.06), JBL: 23.65 (+0.30), HBI: 34.18 (-0.16), DNR: 7.46 (-0.04), HSIC: 143.01 (+2.32), URI: 88.85 (+0.37), MNK: 132.47 (+1.26), ENDP: 92.37 (+0.89), AVP: 7.63 (+0.35), SWKS: 102.05 (+2.48), UHS: 118.76 (+0.03), NFLX: 428.30 (+3.09), HCA: 76.03 (+0.61), BTU: 6.14 (+0.40), LVLT: 55.40 (+0.73), EQIX: 238.95 (+3.05), ESV: 21.05 (+0.25), RDC: 18.62 (-0.30), PETM: 82.98 (+0.03)
Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market
at The Street - Mon Mar 16, 7:15PM CDT
It's creating investment opportunities that just shouldn't exist, Cramer says.
KMI: 42.12 (+0.59), TSLA: 198.08 (+2.43), BIIB: 475.98 (+42.33), MMM: 166.49 (+0.83), ACT: 317.06 (+2.65), SHAK: 46.92 (-0.65), PCYC: 257.85 (-0.21), BMRN: 125.17 (-2.32), NBR: 13.15 (+0.36), SLG: 134.00 (+3.58), RRD: 19.23 (+0.41), CFN: 59.91 (-0.06), TRN: 35.28 (+1.28), CMG: 686.65 (+5.98), HBI: 34.18 (-0.16), DNR: 7.46 (-0.04), PEIX: 10.77 (+0.27), OA: 78.23 (+1.51), HSIC: 143.01 (+2.32), REGN: 488.87 (+2.85), CSCO: 28.44 (+0.18), HRB: 32.90 (+0.61), HYH: 49.26 (+1.03), MU: 28.68 (+0.63), AVP: 7.63 (+0.35), HAR: 136.52 (-0.31), ETN: 68.48 (+0.90), EW: 146.77 (-2.17), DIS: 108.43 (+1.06), AMGN: 170.10 (+0.99), SN: 11.80 (+0.08), BA: 154.50 (+0.39), VOD: 33.96 (+0.81), AA: 12.97 (+0.01), EQIX: 238.95 (+3.05), ISIS: 73.59 (-3.49), ONCE: 69.95 (-4.22), ICPT: 290.98 (+2.47), ULTA: 152.02 (-0.27), VZ: 49.56 (+0.26)
European Regulator Oks Becton, Dickinson-CareFusion Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 12:10PM CDT
Becton, Dickinson and Company (BDX) recently received European Commission's approval for its pending acquisition of CareFusion Corp (CFN).
BDX: 144.72 (-0.21), CAH: 91.25 (+1.33), CFN: 59.91 (-0.06), MMSI: 19.40 (-0.02)
CareFusion (CFN) Crosses Pivot Point Resistance at $60.07
Comtex SmarTrend(R) - Mon Mar 16, 10:48AM CDT
Shares of CareFusion (NYSE:CFN) opened today above their pivot of $59.95 and have already reached the first level of resistance at $60.07. Analysts will be watching for a cross of the next upside pivot targets of $60.16 and $60.37.
CFN: 59.91 (-0.06)
Becton, Dickinson and Company passes European Commission clearance for pending acquisition of CareFusion
M2 - Mon Mar 16, 4:36AM CDT
Medical technology company Becton, Dickinson and Company (NYSE:BDX) reported on Friday the receipt of clearance from the European Commission for the pending acquisition of CareFusion Corporation (NYSE:CFN).
BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P 500, S&P MidCap 400 and S&P SmallCap 600
PR Newswire - Fri Mar 13, 4:50PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
KMI: 42.12 (+0.59), BDX: 144.72 (-0.21), AVP: 7.63 (+0.35), ACT: 317.06 (+2.65), TLMR: 14.77 (-0.05), NBR: 13.15 (+0.36), FCX: 18.41 (+1.15), SLG: 134.00 (+3.58), MHFI: 108.59 (+1.08), BWLD: 187.16 (-1.00), CELG: 128.50 (+3.17), NOV: 49.66 (+1.77), EQIX: 238.95 (+3.05), CFN: 59.91 (-0.06), APA: 59.55 (-0.33), HBI: 34.18 (-0.16), DNR: 7.46 (-0.04), HSIC: 143.01 (+2.32), CELGZ: 3.05 (+0.02)
European Commission Clears BD Acquisition Of CareFusion
PR Newswire - Fri Mar 13, 1:00PM CDT
Becton, Dickinson and Company (NYSE: BDX) ("BD"
and CareFusion Corporation (NYSE: CFN) ("CareFusion" announced today that the companies have received clearance from the European Commission under the EU Merger Regulation for the pending acquisition of CareFusion by BD. The proposed acquisition has now received all necessary regulatory approvals. BDX: 144.72 (-0.21), CFN: 59.91 (-0.06)
CareFusion Shares Up 34.3% Since SmarTrend's Buy Recommendation (CFN)
Comtex SmarTrend(R) - Wed Mar 11, 5:05PM CDT
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 7 months, CareFusion has returned 34.30% as of today's recent price of $59.63.
CFN: 59.91 (-0.06)
Healthcare IT Market in India 2015-2019: Healthcare Providers and Institutions Adopting Corporate Culture with Dell, HCL, HP, TCS & Wipro Dominating
M2 - Tue Mar 10, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/693hmv/healthcare_it) has announced the addition of the "Healthcare IT Market in India 2015-2019" report to their offering. The Healthcare IT market in India to grow at a CAGR of 14.02% over the period 2014-2019 This report covers the present scenario and the growth prospects of the Healthcare IT market in India for the period 2015-2019. The Healthcare IT market is categorized into three segments: Hardware, Software, and IT Services. Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is contributing to the growth of healthcare IT. The demand for advanced analytics tools is one of the key trends in the market. These tools are a significant part of healthcare data analytics solutions, which help healthcare professionals or organizations gain insights from medical records of patients collected from various sources. According to the report, healthcare providers and institutions are increasingly adopting corporate culture, which is fueling demand for IT solutions in the Healthcare industry. Profits are evidently becoming a priority for several hospitals based out of urban India. Further, the report states that high costs of IT adoption are a main concern in India. Healthcare costs are expected to increase rapidly. The initial investment required for installing IT systems is high and continues to increase; however, revenue does not increase proportionally. Varied healthcare practices make it difficult for physicians to invest in installing and maintaining IT systems. Key Vendors - Dell - HCL - HP - TCS - Wipro Other Prominent Vendors - 21st Century Informatics - Accenture - Akhil Systems - Blackberry - C Marc - CareFusion - Cerner - CGEY - Cognizant - CSC - Emdeon - FCG - GE Healthcare - Google - IBM - Infosys - Intel - Isoft - Kaiser Permanente - Microsoft - Misys - Napier Healthcare - Perot Systems - Philips - Qualcomm - Religare Technova - Shivam Medisoft - Siemens - Tech Mahindra - United Healthcare Group For more information visit http://www.researchandmarkets.com/research/69...lthcare_it
WIT: 13.77 (+0.28), IBM: 162.88 (+3.07), CFN: 59.91 (-0.06), QCOM: 70.04 (+0.21), PER: 6.84 (+0.25), CERN: 73.73 (-0.09)
Top 100 Foreign Medical Devices/Technology/Supplies Companies Active in India: 2015
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9rw4tk/foreign_medical) has announced the addition of the "Foreign Medical Devices/Technology/Supplies Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. India's free market environment, developed industry, investment in health infrastructure, increased demand for high quality medical devices, and agreements between foreign device manufacturers and Indian manufacturers are some of the main factors that are responsible for the growth of the Indian medical market. In a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. However, there are presently a sizable number of foreign firms actively pursuing their businesses in India in this sector. The international companies in this field are using India as a manufacturing base by either setting up facilities of their own or by acquiring domestic manufacturers. And, FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. These 100 foreign companies are a stepping-stone to enter India and therefore this report would be beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of foreign countries active in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances with Indian companies - India presence of foreign medical devices/technology/supplies companies - R&D activities by foreign medical devices/technology/supplies companies in India Companies Mentioned - Accuray Inc (United States) - Accuray medical equipment (India) Private Limited - Alcon Japan Ltd.(Japan) - Alcon Laboratories (India) Pvt. Ltd. - Alpha Pro Tech Limited (Canada) - Ambu A/S (Denmark) - Ambu India - Amplifon India Pvt. Ltd. - Amplifon SPA (Italy) - Asahi Intecc Co., Ltd. (Japan) - B. Braun Aesculap Japan Co., Ltd.(Japan) - B.Braun Medical India Pvt. Ltd. - B.L.J. Company Limited(Japan) - BD India Pvt. Ltd. - Bard India Healthcare Private Limited - Bausch & Lomb Eyecare (India) Pvt. Ltd. - Becton, Dickinson and Company (United States) - Boston Scientific Corporation (United States) - Boston Scientific India Pvt. Ltd. - C R Bard Inc (United States) - CHC Group India - CHC Healthcare Group (Taiwan) - CareFusion Development Pvt. Ltd. - Carefusion Corporation (United States) - Coloplast (India) Pvt. Ltd. - Coloplast AS (Denmark) - Coltene Holding AG (Switzerland) - Coltene/Whaledent Private Ltd. - Conmed Corporation (United States) For more information visit http://www.researchandmarkets.com/research/9r...gn_medical
BSX: 17.84 (+0.03), CFN: 59.91 (-0.06), APT: 2.25 (-0.01), ARAY: 8.99 (+0.17)
Hottest Fashion Trends In Stocks - Cramer's Mad Money (2/17/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Feb 18, 6:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, February 17. With the ongoing Fashion Week in New York, Cramer decided to look at the hottest trends on Wall Street. The cyber-security stocks are in style...
GD: 135.41 (+0.13), BDX: 144.72 (-0.21), LMT: 203.77 (+1.58), MDT: 78.02 (+0.36), CYBR: 48.69 (-1.72), SKX: 71.41 (-0.55), KORS: 66.13 (-0.69), INTC: 31.31 (+0.57), PANW: 144.08 (-2.11), SLB: 82.37 (+1.36), BSX: 17.84 (+0.03), FOSL: 83.20 (+0.67), RIG: 14.99 (+0.83), CFN: 59.91 (-0.06), TGT: 81.31 (+0.71), COST: 152.59 (+1.28), AAPL: 125.90 (-1.60), CSCO: 28.44 (+0.18), WFM: 53.97 (+0.35), HRS: 72.75 (+0.57), MU: 28.68 (+0.63), CY: 15.70 (+0.28), HD: 117.49 (+2.33), FEYE: 41.69 (-1.33), BRCM: 46.00 (+1.12), VFC: 75.25 (+1.19), EW: 146.77 (-2.17), TRIP: 86.35 (+2.55), COLM: 59.58 (+0.33), SMH: 57.74 (+0.90), WM: 54.55 (-0.18), PCLN: 1,179.17 (+2.85), WWAV: 42.67 (+0.37), BBBY: 74.87 (-0.74), TJX: 69.47 (+1.31), EXPE: 95.91 (+1.23), JWN: 82.32 (+1.12), FTNT: 35.31 (-0.16), BIG: 50.14 (+0.10)
Insider Trading Alert - CFN, VSR And CAVM Traded By Insiders
at The Street - Wed Feb 11, 11:16AM CST
Stocks with insider trader activity include CFN, VSR and CAVM
CAVM: 73.81 (+1.33), CFN: 59.91 (-0.06), VSR: 3.28 (+0.21)
CareFusion Up 34.5% Since SmarTrend Uptrend Call (CFN)
Comtex SmarTrend(R) - Tue Feb 10, 5:04PM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 6 months, CareFusion has returned 34.46% as of today's recent price of $59.70.
CFN: 59.91 (-0.06)
CareFusion to Distribute Breas Medical's Vivo Ventilators in US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 1:28PM CST
CareFusion Corp (CFN) recently announced the signing of an exclusive distribution agreement with Breas Medical for the latter's Vivo line of ventilation equipment.
BDX: 144.72 (-0.21), ABAX: 65.61 (+1.33), CFN: 59.91 (-0.06), VASC: 30.35 (-0.02)
Codonics and CareFusion Expand Partnership
PR Newswire - Tue Feb 10, 7:40AM CST
Codonics (codonics.com), a global leader in medication safety systems and image documentation solutions, and CareFusion (carefusion.com), a leading global medical technology company, are pleased to announce their expanded partnership. Codonics and CareFusion are working together to develop advanced integration between Codonics technology, CareFusion solutions and Pharmacy Information System (PIS), delivering synchronized formulary management to the operating room (OR).
CFN: 59.91 (-0.06)
Apnea Sciences Announces CareFusion Signs Agreement to Distribute ApneaRx(R)
Business Wire - Mon Feb 09, 9:00AM CST
After Kaiser Permanente Hospitals agreed to purchase Apnea Sciences patented treatment for sleep apnea, ApneaRx(R), www.apnearx.com they needed an experienced distributor. Apnea Sciences selected California-based CareFusion www.carefusion.com to manage all phases of distribution.
CFN: 59.91 (-0.06)
